Calcimimetic R-568 vasodilatory effect on mesenteric vascular beds from normotensive (WKY) and spontaneously hypertensive (SHR) rats. Potential involvement of vascular smooth muscle cells (vSMCs).
The potential role of calcimimetics as vasculotropic agents has been suggested since the discovery that calcium sensing receptors (CaSRs) are expressed in cardiovascular tissues. However, whether this effect is CaSR-dependent or -independent is still unclear. In the present study the vascular activi...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6084966?pdf=render |
id |
doaj-c83f53728d0f4a2092d20abd115d88c3 |
---|---|
record_format |
Article |
spelling |
doaj-c83f53728d0f4a2092d20abd115d88c32020-11-25T02:40:11ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01138e020235410.1371/journal.pone.0202354Calcimimetic R-568 vasodilatory effect on mesenteric vascular beds from normotensive (WKY) and spontaneously hypertensive (SHR) rats. Potential involvement of vascular smooth muscle cells (vSMCs).Natalia Di PietroMaria Assunta PotenzaSara Di SilvestreFrancesco AddabboNadia Di PietrantonioPamela Di TomoCaterina PipinoDomitilla MandatoriCarola PalmeriniPaola FailliMario BonominiMonica MontagnaniAssunta PandolfiThe potential role of calcimimetics as vasculotropic agents has been suggested since the discovery that calcium sensing receptors (CaSRs) are expressed in cardiovascular tissues. However, whether this effect is CaSR-dependent or -independent is still unclear. In the present study the vascular activity of calcimimetic R-568 was investigated in mesenteric vascular beds (MVBs) isolated from Spontaneously Hypertensive rats (SHR) and the relative age-matched Wistar-Kyoto (WKY) control rats. Pre-constricted MBVs were perfused with increasing concentrations of R-568 (10 nM- 30 μM) resulting in a rapid dose-dependent vasodilatation. However, in MVBs from SHR this was preceded by a small but significant vasoconstriction at lowest nanomolar concentrations used (10-300 nM). Pre-treatment with pharmacological inhibitors of nitric oxide (NO) synthase (NOS, L-NAME), KCa channels (CTX), cyclo-oxygenase (INDO) and CaSR (Calhex) or the endothelium removal suggest that NO, CaSR and the endothelium itself contribute to the R-568 vasodilatory/vasoconstrictor effects observed respectively in WKY/SHR MVBs. Conversely, the vasodilatory effects resulted by highest R-568 concentration were independent of these factors. Then, the ability of lower R-568 doses (0.1-1 μM) to activate endothelial-NOS (eNOS) pathway in MVBs homogenates was evaluated. The Akt and eNOS phosphorylation levels resulted increased in WKY homogenates and Calhex significantly blocked this effect. Notably, this did not occur in the SHR. Similarly, vascular smooth muscle cells (vSMCs) stimulation with lower R-568 doses resulted in Akt activation and increased NO production in WKY but not in SHR cells. Interestingly, in these cells this was associated with the absence of the biologically active dimeric form of the CaSR thus potentially contributing to explain the impaired vasorelaxant effect observed in response to R-568 in MVB from SHR compared to WKY. Overall, these findings provide new insight on the mechanisms of action of the calcimimetic R-568 in modulating vascular tone both in physiological and pathological conditions such as hypertension.http://europepmc.org/articles/PMC6084966?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Natalia Di Pietro Maria Assunta Potenza Sara Di Silvestre Francesco Addabbo Nadia Di Pietrantonio Pamela Di Tomo Caterina Pipino Domitilla Mandatori Carola Palmerini Paola Failli Mario Bonomini Monica Montagnani Assunta Pandolfi |
spellingShingle |
Natalia Di Pietro Maria Assunta Potenza Sara Di Silvestre Francesco Addabbo Nadia Di Pietrantonio Pamela Di Tomo Caterina Pipino Domitilla Mandatori Carola Palmerini Paola Failli Mario Bonomini Monica Montagnani Assunta Pandolfi Calcimimetic R-568 vasodilatory effect on mesenteric vascular beds from normotensive (WKY) and spontaneously hypertensive (SHR) rats. Potential involvement of vascular smooth muscle cells (vSMCs). PLoS ONE |
author_facet |
Natalia Di Pietro Maria Assunta Potenza Sara Di Silvestre Francesco Addabbo Nadia Di Pietrantonio Pamela Di Tomo Caterina Pipino Domitilla Mandatori Carola Palmerini Paola Failli Mario Bonomini Monica Montagnani Assunta Pandolfi |
author_sort |
Natalia Di Pietro |
title |
Calcimimetic R-568 vasodilatory effect on mesenteric vascular beds from normotensive (WKY) and spontaneously hypertensive (SHR) rats. Potential involvement of vascular smooth muscle cells (vSMCs). |
title_short |
Calcimimetic R-568 vasodilatory effect on mesenteric vascular beds from normotensive (WKY) and spontaneously hypertensive (SHR) rats. Potential involvement of vascular smooth muscle cells (vSMCs). |
title_full |
Calcimimetic R-568 vasodilatory effect on mesenteric vascular beds from normotensive (WKY) and spontaneously hypertensive (SHR) rats. Potential involvement of vascular smooth muscle cells (vSMCs). |
title_fullStr |
Calcimimetic R-568 vasodilatory effect on mesenteric vascular beds from normotensive (WKY) and spontaneously hypertensive (SHR) rats. Potential involvement of vascular smooth muscle cells (vSMCs). |
title_full_unstemmed |
Calcimimetic R-568 vasodilatory effect on mesenteric vascular beds from normotensive (WKY) and spontaneously hypertensive (SHR) rats. Potential involvement of vascular smooth muscle cells (vSMCs). |
title_sort |
calcimimetic r-568 vasodilatory effect on mesenteric vascular beds from normotensive (wky) and spontaneously hypertensive (shr) rats. potential involvement of vascular smooth muscle cells (vsmcs). |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2018-01-01 |
description |
The potential role of calcimimetics as vasculotropic agents has been suggested since the discovery that calcium sensing receptors (CaSRs) are expressed in cardiovascular tissues. However, whether this effect is CaSR-dependent or -independent is still unclear. In the present study the vascular activity of calcimimetic R-568 was investigated in mesenteric vascular beds (MVBs) isolated from Spontaneously Hypertensive rats (SHR) and the relative age-matched Wistar-Kyoto (WKY) control rats. Pre-constricted MBVs were perfused with increasing concentrations of R-568 (10 nM- 30 μM) resulting in a rapid dose-dependent vasodilatation. However, in MVBs from SHR this was preceded by a small but significant vasoconstriction at lowest nanomolar concentrations used (10-300 nM). Pre-treatment with pharmacological inhibitors of nitric oxide (NO) synthase (NOS, L-NAME), KCa channels (CTX), cyclo-oxygenase (INDO) and CaSR (Calhex) or the endothelium removal suggest that NO, CaSR and the endothelium itself contribute to the R-568 vasodilatory/vasoconstrictor effects observed respectively in WKY/SHR MVBs. Conversely, the vasodilatory effects resulted by highest R-568 concentration were independent of these factors. Then, the ability of lower R-568 doses (0.1-1 μM) to activate endothelial-NOS (eNOS) pathway in MVBs homogenates was evaluated. The Akt and eNOS phosphorylation levels resulted increased in WKY homogenates and Calhex significantly blocked this effect. Notably, this did not occur in the SHR. Similarly, vascular smooth muscle cells (vSMCs) stimulation with lower R-568 doses resulted in Akt activation and increased NO production in WKY but not in SHR cells. Interestingly, in these cells this was associated with the absence of the biologically active dimeric form of the CaSR thus potentially contributing to explain the impaired vasorelaxant effect observed in response to R-568 in MVB from SHR compared to WKY. Overall, these findings provide new insight on the mechanisms of action of the calcimimetic R-568 in modulating vascular tone both in physiological and pathological conditions such as hypertension. |
url |
http://europepmc.org/articles/PMC6084966?pdf=render |
work_keys_str_mv |
AT nataliadipietro calcimimeticr568vasodilatoryeffectonmesentericvascularbedsfromnormotensivewkyandspontaneouslyhypertensiveshrratspotentialinvolvementofvascularsmoothmusclecellsvsmcs AT mariaassuntapotenza calcimimeticr568vasodilatoryeffectonmesentericvascularbedsfromnormotensivewkyandspontaneouslyhypertensiveshrratspotentialinvolvementofvascularsmoothmusclecellsvsmcs AT saradisilvestre calcimimeticr568vasodilatoryeffectonmesentericvascularbedsfromnormotensivewkyandspontaneouslyhypertensiveshrratspotentialinvolvementofvascularsmoothmusclecellsvsmcs AT francescoaddabbo calcimimeticr568vasodilatoryeffectonmesentericvascularbedsfromnormotensivewkyandspontaneouslyhypertensiveshrratspotentialinvolvementofvascularsmoothmusclecellsvsmcs AT nadiadipietrantonio calcimimeticr568vasodilatoryeffectonmesentericvascularbedsfromnormotensivewkyandspontaneouslyhypertensiveshrratspotentialinvolvementofvascularsmoothmusclecellsvsmcs AT pameladitomo calcimimeticr568vasodilatoryeffectonmesentericvascularbedsfromnormotensivewkyandspontaneouslyhypertensiveshrratspotentialinvolvementofvascularsmoothmusclecellsvsmcs AT caterinapipino calcimimeticr568vasodilatoryeffectonmesentericvascularbedsfromnormotensivewkyandspontaneouslyhypertensiveshrratspotentialinvolvementofvascularsmoothmusclecellsvsmcs AT domitillamandatori calcimimeticr568vasodilatoryeffectonmesentericvascularbedsfromnormotensivewkyandspontaneouslyhypertensiveshrratspotentialinvolvementofvascularsmoothmusclecellsvsmcs AT carolapalmerini calcimimeticr568vasodilatoryeffectonmesentericvascularbedsfromnormotensivewkyandspontaneouslyhypertensiveshrratspotentialinvolvementofvascularsmoothmusclecellsvsmcs AT paolafailli calcimimeticr568vasodilatoryeffectonmesentericvascularbedsfromnormotensivewkyandspontaneouslyhypertensiveshrratspotentialinvolvementofvascularsmoothmusclecellsvsmcs AT mariobonomini calcimimeticr568vasodilatoryeffectonmesentericvascularbedsfromnormotensivewkyandspontaneouslyhypertensiveshrratspotentialinvolvementofvascularsmoothmusclecellsvsmcs AT monicamontagnani calcimimeticr568vasodilatoryeffectonmesentericvascularbedsfromnormotensivewkyandspontaneouslyhypertensiveshrratspotentialinvolvementofvascularsmoothmusclecellsvsmcs AT assuntapandolfi calcimimeticr568vasodilatoryeffectonmesentericvascularbedsfromnormotensivewkyandspontaneouslyhypertensiveshrratspotentialinvolvementofvascularsmoothmusclecellsvsmcs |
_version_ |
1724782564765335552 |